Agreement also calls for NHS to increase net price it pays for new medicines by 25%
The expected deal follows threats of tariffs as high as 100% on branded drug imports.
The U.S. announced a deal with Britain for zero tariffs on pharmaceutical products and medical technology which will lead to Britain spending more on medicines.
The deal involves a major change in how the UK values drugs and will apply to all new medicines, not just US ones.
The United States and the United Kingdom have agreed on a zero-tariffs deal for medications manufactured in Britain. The NHS will pay more for drugs.
